|
Immunicum welcomes Per-Olof Gunnesson as new member of the Board. He has over 40 years of experience from the pharmaceutical industry, including several management positions at the Astra Group where he among other things acted as Vice President of Finance and Licensing. |
|
|
Immunicum submits a provisional patent application, METHOD FOR PROLIFERATION OF ANTIGEN-SPECIFIC T CELLS, to the USPTO (application number: 61/255,146) and to the Swedish Patent and Registration Office (application number: 0950797-1) to protect its CD70-concept against cancer. |
|
Immunicum's CSO, Alex Karlsson-Parra, speaks at the 14th World Congress on Advances in Oncology and the 12th International Symposium on Molecular Medicine between 15-17 October, 2009, at Hotel Poseidon Resort in Loutraki, Greece. The topic of his presentation is "A multi-modality approach in cancer immunotherapy". |
|
CEO, Jamal El-Mosleh, holds a company presentation at Park Annual 09. |
|
Immunicum welcomes biologist Juliana Kovacka as part of the R&D-team! |
|
Frost & Sullivan features Immunicum in their "Genetic Technology Alert". |
|
Immunicum is presented in Göteborgs-Posten. Read the article here . |
|
Immunicum's CEO, Jamal El-Mosleh, holds a company presentation at UK-Nordic Oncology Conference in Copenhagen.
|
|
Read more...
|
|
Immunicum rents laboratory space at Sahlgrenska Science Park. |
|
|
|
|
|
